Is a complete NMRA research report available?

No complete published report is available for Neumora Therapeutics, Inc. (NMRA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Neumora Therapeutics, Inc. (NMRA)

NASDAQ: NMRA · USD

$1.65

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NMRA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	305.7M
Net income (ttm)	-222.4M
EPS (ttm)	-$1.32
Shares out	185.3M
Volume	511,332
Beta	2.77
Price target	$6.28	+280.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -222.4M
EPS (ttm): -$1.32
Market cap: 305.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NMRA indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001885522
Company name	Neumora Therapeutics, Inc.
Country	United States
Country code	US
Cusip	640979100
Employees	92
Employees Change	-4%
Employees Change Percent	-4.17
Enterprise value	$212M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2023-09-15
Isin	US6409791000
Last refreshed	2026-07-31
Market cap	$305.7M
Market cap category	Small-Cap
Price	$1.65
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2836
Symbol	NMRA
Website	https://www.neumoratx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-72.74%
FCF yield	-63.26%
P/B ratio	4.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-222.4M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Profit Per Employee	$-2.4M
ROA	-66.39
Roa5y	-31.61
ROCE	-180.3
ROE	-148.7
Roe5y	-70.61
ROIC	-77.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-24.67%
EPS Growth Quarters	4
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$153.9M
Cash	$147.1M
Current Assets	$153.4M
Current Liabilities	$30.1M
Debt	$53.4M
Debt Equity	$0.76
Equity	$70.7M
Interest Coverage	-43.97
Liabilities	$83.2M
Long Term Assets	$443,000
Long Term Liabilities	$53.1M
Net Cash	$93.7M
Net Cash By Market Cap	$30.65
Net Cash Growth	-62.28%
Net Debt Equity	$-1.33
Tangible Book Value	$70.7M
Tangible Book Value Per Share	$0.39
WACC	17.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.09
Net Working Capital	$-23.5M
Quick ratio	4.88
Working Capital	$123.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.83%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-24.66%
200-day SMA	2.18
50-day SMA	1.65
50-day SMA vs 200-day SMA	50under200
All Time High	21
All Time High Change	-92.14%
All Time High Date	2024-03-08
All Time Low	0.61
All Time Low Change	170.05%
All Time Low Date	2025-05-14
ATR	0.12
Beta	2.77
Beta1y	1.63
Beta2y	2.29
Ch YTD	-7.82
High	1.69
High52	3.65
High52 Date	2026-02-18
High52ch	-54.79%
Low	1.62
Low52	0.83
Low52 Date	2026-06-15
Low52ch	98.75%
Ma50ch	0.06%
Premarket Change Percent	-1.59
Premarket Price	$1.62
Premarket Volume	444
Price vs 200-day SMA	-24.21%
RSI	51.13
RSI Monthly	38.3
RSI Weekly	42.48
Sharpe ratio	0.35x
Sortino ratio	0.65
Total Return	-4.83%
Tr YTD	-7.82
Tr1m	-4.07%
Tr1w	5.77%
Tr3m	-26.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	8
Analyst Price Target Top	$6.33
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.24
Operating Income	$-218.1M
Price target	$6.28
Price Target Change	$281
Price Target Change Top	$284

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113,847,078%
Float Percent	61.44%
Net Borrowing	57,161,000
Shares Insiders	4.46%
Shares Institutions	38.47%
Shares Out	185,284,244
Shares Qo Q	6.74%
Shares Yo Y	4.83%
Short Float	6.84%
Short Ratio	1.84
Short Shares	4.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-221.4M
Adjusted OCF	-221,353,000
Average Volume	811,225.05x
Bv Per Share	0.39
Ch1m	-4.07
Ch1w	5.77
Ch1y	-24.66
Ch3m	-26.67
Ch6m	-19.51
Change	0%
Change From Open	0
Close	1.65
Days Gap	0
Depreciation Amortization	59,000
Dollar Volume	843,697.8
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-223.1M
EBITDA	$-223M
EPS	$-1.32
F Score	1
FCF	$-193.4M
FCF EV Yield	-91.22x
FCF Per Share	$-1.04
Financing CF	87,964,000
Fiscal Year End	December
Founded	2,019
Income Tax	$55,000
Investing CF	124,431,000
Ipr	-90.29
Iprfo	-90
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-30
Ma150	2.14
Ma150ch	-22.86%
Ma20	1.63
Ma20ch	1.54%
Net CF	18,999,000
Next Earnings Date	2026-08-10
Open	1.65
Optionable	Yes
Position In Range	46.15
Post Close	1.65
Postmarket Change Percent	-2.42
Postmarket Price	$1.61
Ppne	390,000
Pre Close	1.65
Price Date	2026-07-30
Ptbv Ratio	4.33
Relative Volume	0.63x
Share Based Comp	27,957,000
Tr6m	-19.51%
Us State	Massachusetts
Volume	511,332

Neumora Therapeutics, Inc. (NMRA)

Coverage state: Market snapshot only — no published research

Generate the first NMRA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · NMRA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NMRA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NMRA

Frequently asked questions